Nahdi Medical Co (SAU:4164) Research & Development: ﷼0 Mil (TTM As of Mar. 2026)


SAU:4164 Nahdi Medical Co SAU:4164
61 GF Score
Price ﷼93.25
GF Value ﷼140.28
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Nahdi Medical Co Research & Development?

Nahdi Medical Co SAU:4164 -0.80% 61 Research & Development is ﷼0 Mil as of Mar. 2026. GuruFocus rates SAU:4164 with a GF Score™ of 61/100 and a GF Value™ of ﷼140.28 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Nahdi Medical Co's Research & Development for the three months ended in Mar. 2026 was ﷼0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ﷼0 Mil.

Nahdi Medical Co  (SAU:4164) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Nahdi Medical Co Research & Development Related Terms

Nahdi Medical Co Research & Development Historical Data

* Premium members only.

The historical data trend for Nahdi Medical Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nahdi Medical Co Research & Development Chart

Nahdi Medical Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
0.00 0.00 0.00 0.00 0.00

Nahdi Medical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SAU:4164
61GF Score
Nahdi Medical Co SAU:4164
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nahdi Medical Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ﷼0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ﷼0 Mil mean?
Nahdi Medical Co (SAU:4164) has a Research & Development of ﷼0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Nahdi Medical Co and its competitors.
Is Nahdi Medical Co's Research & Development too high?
Nahdi Medical Co's current Research & Development is ﷼0 Mil. Overall, Nahdi Medical Co has a GF Score™ of 61/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nahdi Medical Co's Research & Development compare to competitors?
Nahdi Medical Co's Research & Development of ﷼0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Nahdi Medical Co and its competitors. Nahdi Medical Co's current Research & Development is ﷼0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nahdi Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Nahdi Medical Co (SAU:4164) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼140.28, compared to a current price of ﷼93.25 — trading 33.5% below its estimated fair value. The current Research & Development is ﷼0 Mil. Nahdi Medical Co's overall GF Score™ is 61/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Nahdi Medical Co (SAU:4164), the current Research & Development is ﷼0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nahdi Medical Co (SAU:4164) Overvalued in 2026?

Based on GuruFocus' analysis, Nahdi Medical Co stock appears to be undervalued. The current stock price of ﷼93.25 is trading 33.5% below its estimated GF Value™ of ﷼140.28. GuruFocus considers Nahdi Medical Co to be Significantly Undervalued.

Key valuation signals for SAU:4164:

  • Research & Development: ﷼0 Mil
  • GF Value™: ﷼140.28 vs. price of ﷼93.25 (33.5% below fair value)
  • GF Score™: 61/100 with 2 warning signs

No single metric tells the full story. See the SAU:4164 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nahdi Medical Co Business Description

Address Ibrg Alraghama, PO Box 17129, Jeddah, SAU, 21484
Nahdi Medical Co is engaged in the wholesale and retail trading of cosmetics, pharmaceutical products, special and healthy foods, and medical equipment. It has two operating segments: Front Shop and Pharma.
61GF Score

Get the complete analysis for SAU:4164

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼93.25
Price
﷼140.28
GF Value